Mikel Berdud : Citation Profile


Are you Mikel Berdud?

Office of Health Economics

3

H index

0

i10 index

24

Citations

RESEARCH PRODUCTION:

2

Articles

17

Papers

RESEARCH ACTIVITY:

   10 years (2012 - 2022). See details.
   Cites by year: 2
   Journals where Mikel Berdud has often published
   Relations with other researchers
   Recent citing documents: 1.    Total self citations: 1 (4 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pbe1130
   Updated: 2024-01-16    RAS profile: 2022-09-20    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Mikel Berdud.

Is cited by:

Brassel, Simon (2)

Shah, Koonal (1)

Neri, Margherita (1)

Husereau, Don (1)

Graf von der Schulenburg, Johann (1)

Lorgelly, Paula (1)

Straume, Odd Rune (1)

Han, Euna (1)

Blankart, Katharina (1)

Brekke, Kurt (1)

Garau, Martina (1)

Cites to:

Tirole, Jean (14)

Jewitt, Ian (10)

Dewatripont, Mathias (10)

Ghatak, Maitreesh (6)

Hwang, Sung-Ha (6)

Towse, Adrian (5)

Danzon, Patricia (4)

Mueller, Hannes (4)

Delfgaauw, Josse (3)

Newhouse, Joseph (3)

Frey, Bruno (3)

Main data


Where Mikel Berdud has published?


Working Papers Series with more than one paper published# docs
Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra / Departamento de Economía - Universidad Pública de Navarra6

Recent works citing Mikel Berdud (2024 and 2023)


YearTitle of citing document
2023The price of cost-effectiveness thresholds. (2023). Straume, Odd Rune ; Dalen, Dag Morten ; Brekke, Kurt R. In: Discussion Paper Series in Economics. RePEc:hhs:nhheco:2023_004.

Full description at Econpapers || Download paper

Works by Mikel Berdud:


YearTitleTypeCited
2019The Future of Global Health Procurement: Issues around Pricing Transparency In: Working Papers.
[Full Text][Citation analysis]
paper3
2022Alternative funding models for medical innovation: the role of product development partnerships in product innovation for infectious diseases In: Post-Print.
[Citation analysis]
paper0
2012Incentives Beyond the Money and Motivational Capital in Health Care Organizations. In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2012Motivational Capital and Incentives in Health Care Organisations. In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2014Motivational Capital and Incentives in Health Care Organizations.(2014) In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0
paper
2014Motivational Capital and Incentives in Health Care Organizations.(2014) In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 0
paper
2012Incentives Beyond the Money: Identity and Motivational Capital in Public Organizations In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2014A Pilot Inquiry on Incentives and Intrinsic Motivation in Health Care: the Motivational Capital Explained by Doctors In: Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra.
[Full Text][Citation analysis]
paper0
2017Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market In: Consulting Report.
[Full Text][Citation analysis]
paper1
2018Review of CRA’s Report “Assessing the Economic Impacts of Changing Exemption Provisions During Patent and SPC Protection in Europe†In: Consulting Report.
[Full Text][Citation analysis]
paper0
2020A Bargaining Approach: A Theory on ICER Pricing and Optimal Level of Cost-Effectiveness Threshold In: Consulting Report.
[Full Text][Citation analysis]
paper3
2021Key Factors on How to Procure, Pay, Distribute and Use Vaccines for COVID-19: A European Perspective In: Consulting Report.
[Full Text][Citation analysis]
paper0
2017Macro Evaluation of the NIHR Oxford Biomedical Research Centre In: Research Paper.
[Full Text][Citation analysis]
paper0
2018Establishing a Reasonable Price for an Orphan Drug In: Research Paper.
[Full Text][Citation analysis]
paper2
2018R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C In: Research Paper.
[Full Text][Citation analysis]
paper4
2019The Future of Global Health Procurement: Issues around Pricing Transparency In: Research Paper.
[Full Text][Citation analysis]
paper3
2019The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK In: Research Paper.
[Full Text][Citation analysis]
paper0
2016Fostering incentives for research, development, and delivery of interventions for neglected tropical diseases: lessons from malaria In: Oxford Review of Economic Policy.
[Full Text][Citation analysis]
article0
2016Biosimilars: How Can Payers Get Long-Term Savings? In: PharmacoEconomics.
[Full Text][Citation analysis]
article8

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated December, 10 2023. Contact: CitEc Team